EDELRIS

EDELRIS is a leading biotechnology research company dedicated to the design and chemical synthesis of innovative natural product-like screening libraries. Focusing on accelerating the lead discovery and optimization process in pharma and biotech research organizations, EDELRIS leverages its recognized chemistry and screening expertise in drug discovery to provide novelty to its clients and partners. The company's unique NP-like screening libraries contain millions of in-house synthesized compounds, offering built-in hit-to-lead optimization capabilities. EDELRIS's primary address is 60, Avenue Rockefeller, Lyon, Auvergne-Rhône-Alpes 69008, FR.

With a wide range of services, EDELRIS provides state-of-the-art target qualification (protein and RNA), screening, and hit identification capacities, applying in-house Affinity Selection – Mass Spectrometry (AS-MS) technologies. The company also has a considerable chemical analysis department supporting its broad portfolio of ongoing organic and medicinal chemistry projects and screening campaigns. When partnering with EDELRIS, clients gain access to innovative solutions for synthetic and medicinal chemistry challenges.

The EDELRIS team is committed to creating value for every project. The company's dedication to excellence and innovation makes it a trusted partner in the biotechnology and pharmaceutical industries. We invite the manager of EDELRIS to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.